Cargando…

Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis

Detalles Bibliográficos
Autores principales:	Vazquez, Romain, Breal, Claire, Zalmai, Loria, Friedrich, Chloe, Almire, Carole, Contejean, Adrien, Barreau, Sylvain, Grignano, Eric, Willems, Lise, Deau-Fischer, Benedicte, Franchi, Patricia, Vignon, Marguerite, Decroocq, Justine, Birsen, Rudy, Goldwirt, Lauriane, Kaltenbach, Sophie, Couronne, Lucile, Fontenay, Michaela, Kosmider, Olivier, Bouscary, Didier, Chapuis, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979724/ https://www.ncbi.nlm.nih.gov/pubmed/33741892 http://dx.doi.org/10.1038/s41408-021-00448-w

Ejemplares similares

Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients
por: Balducci, Estelle, et al.
Publicado: (2022)

Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein
por: Grignano, E., et al.
Publicado: (2023)

Management of Gastro-Intestinal Toxicity of the Pi3 Kinase Inhibitor: Optimizing Future Dosing Strategies
por: Breal, Claire, et al.
Publicado: (2023)

Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
por: Johnson, Natacha, et al.
Publicado: (2023)

APR-246 induces early cell death by ferroptosis in acute myeloid leukemia
por: Birsen, Rudy, et al.
Publicado: (2021)

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
por: Grignano, Eric, et al.
Publicado: (2020)

Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice
por: Fouquet, G., et al.
Publicado: (2021)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
por: Dussiau, Charles, et al.
Publicado: (2023)

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era
por: Zerbit, Jeremie, et al.
Publicado: (2022)

A colonic mass revealing a disseminated crystal storing histiocytosis secondary to indolent multiple myeloma: a case report with literature review
por: Contejean, Adrien, et al.
Publicado: (2020)

Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia
por: Meunier, Godelieve, et al.
Publicado: (2020)

Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy
por: Fouquet, Guillemette, et al.
Publicado: (2021)

Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia
por: Chapuis, Nicolas, et al.
Publicado: (2019)

Extramedullary haematopoiesis in the kidney
por: Ricci, Davide, et al.
Publicado: (2012)

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
por: Henriquez, Soledad, et al.
Publicado: (2022)

MicroRNAs as Haematopoiesis Regulators
por: Undi, Ram Babu, et al.
Publicado: (2013)

Tribbles in normal and malignant haematopoiesis
por: Stein, Sarah J., et al.
Publicado: (2015)

Updates on Old and Weary Haematopoiesis
por: Konieczny, Joanna, et al.
Publicado: (2018)

Pediatric haematopoiesis and related malignancies
por: Jin, Mingwei, et al.
Publicado: (2017)

The MLL/SET family and haematopoiesis()
por: Antunes, Eric T.B., et al.
Publicado: (2020)

Pediatric haematopoiesis and related malignancies
por: Jin, Mingwei, et al.
Publicado: (2021)

Heterochromatin and Polycomb as regulators of haematopoiesis
por: Keenan, Christine R.
Publicado: (2021)

Germline risk of clonal haematopoiesis
por: Silver, Alexander J., et al.
Publicado: (2021)

Haematopoiesis in Zebrafish (Danio Rerio)
por: Stosik, Michał, et al.
Publicado: (2022)

FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells
por: Levavasseur, Francoise, et al.
Publicado: (2023)

Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)
por: Detroit, Marion, et al.
Publicado: (2023)

The Role of Translation Initiation Regulation in Haematopoiesis
por: Grech, Godfrey, et al.
Publicado: (2012)

Decoding human fetal liver haematopoiesis
por: Popescu, Dorin-Mirel, et al.
Publicado: (2019)

Fat for fuel: lipid metabolism in haematopoiesis
por: Pernes, Gerard, et al.
Publicado: (2019)

Diagnostic imaging of intrathoracic extramedullary haematopoiesis
por: Takeda, Kenichiro, et al.
Publicado: (2023)

Antimicrobial stewardship in high-risk febrile neutropenia patients
por: Contejean, Adrien, et al.
Publicado: (2022)

Calcineurin/NFAT signalling inhibits myeloid haematopoiesis
por: Fric, Jan, et al.
Publicado: (2012)

Paraspinal mass in thalassaemia is often extramedullary haematopoiesis
por: Pandey, Gaurav, et al.
Publicado: (2015)

A perisinusoidal niche for extramedullary haematopoiesis in the spleen
por: Inra, Christopher N., et al.
Publicado: (2015)

Transcriptional network control of normal and leukaemic haematopoiesis
por: Sive, Jonathan I., et al.
Publicado: (2014)

Surgical resection of extramedullary haematopoiesis in the posterior mediastinum
por: Matsumoto, Ryoichi, et al.
Publicado: (2018)

Clonal haematopoiesis is not prevalent in survivors of childhood cancer
por: Collord, Grace, et al.
Publicado: (2017)

YAP and TAZ are dispensable for physiological and malignant haematopoiesis
por: Donato, Elisa, et al.
Publicado: (2018)

The longitudinal dynamics and natural history of clonal haematopoiesis
por: Fabre, Margarete A., et al.
Publicado: (2022)

Clonal dynamics of haematopoiesis across the human lifespan
por: Mitchell, Emily, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5f3eg9eqd24h7i5ok6k8qq72d2